Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: SJS/TEN overlap syndrome | Stevens-Johnson/TEN overlap syndrome | Stevens-Johnson/toxic epidermal necrolysis overlap syndrome

An intermediate form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterized by destruction and detachment of the skin epithelium involving between 10 to 29% of the body surface area and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants antibacterial sulfonamides allopurinol nevirapine and oxicams (non-steroidal anti-inflammatory drugs) but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterized by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous ocular and psychological) are frequent.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on Data version June 2024

Newly diagnosed with
Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Clinical Trials

For a list of clinical trials in this disease area, please click here.